Cellzome is a privately-owned drug discovery company identifying a new generation of kinase- targeted drugs to treat inflammatory diseases. Its pipeline of small-molecule therapeutics is driven by Kinobeads™, a proprietary technology for the screening and profiling of kinases in relevant cells and tissues.
Cellzome is applying its distinctive Kinobeads™ technology to the discovery and development of novel, selective, kinase inhibitors targeting key inflammatory mediators in immune receptor signalling and chemotaxis, including PI3Kγ and Zap-70.
Company Details
- Employees
- 36
- Founded
- -
- Phone
- 499193153362
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- cellzome.com
- Keywords
- proteomics, drug discovery, inflammation.
Cellzome Questions
Cellzome's helpline number is 499193153362
Cellzome's website is cellzome.com
Cellzome's LinkedIn profile is https://uk.linkedin.com/company/cellzome
Cellzome has
36 employees.
View email and phone details for 36
employees at Cellzome.
Cellzome's industry is
Pharmaceutical Manufacturing
Cellzome's top competitors are
Immatics,
Proxygen,
Bavarian Nordic,
Abberior,
Bioanalytix,
Biontech Se,
Full-Life Technologies,
Embl,
Affimed,
Gsk.
Cellzome's categories are Pharmaceutical Manufacturing
Cellzome's founding year is 2000
